Transcriptional	O
and	O
post-transcriptional	O
regulation	O
of	O
c-jun	B-DNA
expression	O
during	O
monocytic	O
differentiation	O
of	O
human	B-cell_line
myeloid	I-cell_line
leukemic	I-cell_line
cells	I-cell_line
.	O

AP-1	B-protein
,	O
the	O
polypeptide	O
product	O
of	O
c-jun	B-DNA
,	O
recognizes	O
and	O
binds	O
to	O
specific	O
DNA	O
sequences	O
and	O
stimulates	O
transcription	O
of	O
genes	B-DNA
responsive	O
to	O
certain	O
growth	O
factors	O
and	O
phorbol	O
esters	O
such	O
as	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
.	O

We	O
studied	O
the	O
effects	O
of	O
TPA	O
on	O
the	O
regulation	O
of	O
c-jun	B-DNA
gene	O
expression	O
in	O
HL-60	B-cell_line
cells	I-cell_line
during	O
monocytic	O
differentiation	O
.	O

Low	O
levels	O
of	O
c-jun	B-RNA
transcripts	I-RNA
were	O
detectable	O
in	O
untreated	B-cell_line
HL-60	I-cell_line
leukemic	I-cell_line
cells	I-cell_line
,	O
increased	O
significantly	O
by	O
6	O
h	O
,	O
and	O
reached	O
near	O
maximal	O
levels	O
by	O
24	O
h	O
of	O
exposure	O
to	O
32	O
nM	O
TPA	O
.	O

Similar	O
kinetics	O
of	O
c-jun	B-DNA
induction	O
by	O
TPA	O
were	O
observed	O
in	O
human	B-cell_line
U-937	I-cell_line
and	O
THP-1	B-cell_line
monocytic	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
.	O

Similar	O
findings	O
were	O
obtained	O
with	O
bryostatin	O
1	O
(	O
10	O
nM	O
)	O
,	O
another	O
activator	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
and	O
inducer	O
of	O
monocytic	O
differentiation	O
.	O

Furthermore	O
,	O
1	O
,	O
25-dihydroxyvitamin	O
D3	O
(	O
0.5	O
microM	O
)	O
,	O
a	O
structurally	O
distinct	O
agent	O
which	O
also	O
induces	O
HL-60	O
monocytic	O
differentiation	O
,	O
increased	O
c-jun	B-DNA
expression	O
.	O

TPA	O
treatment	O
of	O
HL-60	B-cell_line
cells	I-cell_line
in	O
the	O
presence	O
of	O
cycloheximide	O
was	O
associated	O
with	O
superinduction	O
of	O
c-jun	B-DNA
transcripts	O
.	O

Run-on	O
analysis	O
demonstrated	O
detectable	O
levels	O
of	O
c-jun	B-DNA
gene	O
transcription	O
in	O
untreated	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
,	O
and	O
that	O
exposure	O
to	O
TPA	O
increases	O
this	O
rate	O
3.3-fold	O
.	O

Treatment	O
of	O
HL-60	B-cell_line
cells	I-cell_line
with	O
both	O
TPA	O
and	O
cycloheximide	O
had	O
no	O
effect	O
on	O
the	O
rates	O
of	O
c-jun	B-DNA
transcription	O
.	O

The	O
half-life	O
of	O
c-jun	B-RNA
RNA	I-RNA
as	O
determined	O
by	O
treating	O
HL-60	B-cell_line
cells	I-cell_line
with	O
TPA	O
and	O
actinomycin	O
D	O
was	O
30	O
min	O
.	O

In	O
contrast	O
,	O
the	O
half-life	O
of	O
c-jun	B-RNA
RNA	I-RNA
in	O
TPA-treated	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
exposed	O
to	O
cycloheximide	O
and	O
actinomycin	O
D	O
was	O
greater	O
than	O
2	O
h	O
.	O

These	O
findings	O
suggested	O
that	O
the	O
increase	O
in	O
c-jun	B-RNA
RNA	I-RNA
observed	O
during	O
TPA-induced	O
monocytic	O
differentiation	O
is	O
mediated	O
by	O
both	O
transcriptional	O
and	O
post-transcriptional	O
mechanisms	O
.	O

THE	NULL
JoURNAL	NULL
OF	NULL
BtOLOGICAL	NULL
CHEMISTRY	NULL
©1990	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

265	NULL
,	NULL
No	NULL
.	NULL

6	NULL
,	NULL
Issue	NULL
of	NULL
February	NULL
25	NULL
,	NULL
pp	NULL
.	NULL

3320-3323	NULL
,	NULL
1990	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Transcriptional	NULL
and	NULL
Post-transcriptional	NULL
Regulation	NULL
of	NULL
c-jun	NULL
Expression	NULL
during	NULL
Monocytic	NULL
Differentiation	NULL
of	NULL
Human	NULL
Myeloid	NULL
Leukemic	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
19	NULL
,	NULL
1989	NULL
)	NULL
Matthew	NULL
L.	NULL
Shermant	NULL
,	NULL
Richard	NULL
M.	NULL
Stone	NULL
,	NULL
Rakesh	NULL
Datta	NULL
,	NULL
Steven	NULL
H.	NULL
Bernstein	NULL
,	NULL
and	NULL
Donald	NULL
W.	NULL
Kufe	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Clinical	NULL
Pharmacology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
AP-1	NULL
,	NULL
the	NULL
polypeptide	NULL
product	NULL
of	NULL
c-jun	NULL
,	NULL
recognizes	NULL
and	NULL
binds	NULL
to	NULL
specific	NULL
DNA	NULL
sequences	NULL
and	NULL
stimulates	NULL
transcription	NULL
of	NULL
genes	NULL
responsive	NULL
to	NULL
certain	NULL
growth	NULL
factors	NULL
and	NULL
phorbol	NULL
esters	NULL
such	NULL
as	NULL
12-O-tetradeca-noylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
.	NULL

We	NULL
studied	NULL
the	NULL
effects	NULL
of	NULL
TPA	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
c-jun	NULL
gene	NULL
expression	NULL
in	NULL
HL-60	NULL
cells	NULL
during	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
c-jun	NULL
transcripts	NULL
were	NULL
detectable	NULL
in	NULL
untreated	NULL
HL-60	NULL
leukemic	NULL
cells	NULL
,	NULL
increased	NULL
significantly	NULL
by	NULL
6	NULL
h	NULL
,	NULL
and	NULL
reached	NULL
near	NULL
maximal	NULL
levels	NULL
by	NULL
24	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
32	NULL
nm	NULL
TPA	NULL
.	NULL

Similar	NULL
kinetics	NULL
of	NULL
c-jun	NULL
induction	NULL
by	NULL
TPA	NULL
were	NULL
observed	NULL
in	NULL
human	NULL
U-937	NULL
and	NULL
THP-1	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
with	NULL
bryostatin	NULL
1	NULL
(	NULL
10	NULL
nM	NULL
)	NULL
,	NULL
another	NULL
activator	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
inducer	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Furthermore	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
0.5	NULL
uM	NULL
)	NULL
,	NULL
a	NULL
structurally	NULL
distinct	NULL
agent	NULL
which	NULL
also	NULL
induces	NULL
HL-60	NULL
monocytic	NULL
differentiation	NULL
,	NULL
increased	NULL
c-jun	NULL
expression	NULL
.	NULL

TPA	NULL
treatment	NULL
of	NULL
HL-60	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
was	NULL
associated	NULL
with	NULL
superinduction	NULL
of	NULL
c-jun	NULL
transcripts	NULL
.	NULL

Run-on	NULL
analysis	NULL
demonstrated	NULL
detectable	NULL
levels	NULL
of	NULL
c-jun	NULL
gene	NULL
transcription	NULL
in	NULL
untreated	NULL
HL-60	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
exposure	NULL
to	NULL
TPA	NULL
increases	NULL
this	NULL
rate	NULL
3.3-fold	NULL
.	NULL

Treatment	NULL
of	NULL
HL-60	NULL
cells	NULL
with	NULL
both	NULL
TPA	NULL
and	NULL
cycloheximide	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
rates	NULL
of	NULL
c-jun	NULL
transcription	NULL
.	NULL

The	NULL
half-life	NULL
of	NULL
c-jun	NULL
RNA	NULL
as	NULL
determined	NULL
by	NULL
treating	NULL
HL-60	NULL
cells	NULL
with	NULL
TPA	NULL
and	NULL
actinomycin	NULL
D	NULL
was	NULL
30	NULL
min	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
c-jun	NULL
RNA	NULL
in	NULL
TPA-treated	NULL
HL-60	NULL
cells	NULL
exposed	NULL
to	NULL
cycloheximide	NULL
and	NULL
actinomycin	NULL
D	NULL
was	NULL
greater	NULL
than	NULL
2	NULL
h.	NULL
These	NULL
findings	NULL
suggested	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
c-jun	NULL
RNA	NULL
observed	NULL
during	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
is	NULL
mediated	NULL
by	NULL
both	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
mechanisms	NULL
.	NULL

Avian	NULL
sarcoma	NULL
virus	NULL
17	NULL
,	NULL
isolated	NULL
from	NULL
a	NULL
spontaneously	NULL
growing	NULL
chicken	NULL
sarcoma	NULL
,	NULL
is	NULL
a	NULL
retrovirus	NULL
which	NULL
induces	NULL
fibro-sarcomas	NULL
in	NULL
chickens	NULL
and	NULL
neoplastic	NULL
transformation	NULL
of	NULL
cultured	NULL
chicken	NULL
embryo	NULL
fibroblasts	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Avian	NULL
sarcoma	NULL
virus	NULL
17	NULL
contains	NULL
the	NULL
v-jun	NULL
oncogene	NULL
whose	NULL
product	NULL
is	NULL
a	NULL
55-kDa	NULL
gag	NULL
*	NULL
This	NULL
investigation	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
CA42802	NULL
and	NULL
CAO01092	NULL
(	NULL
to	NULL
M.	NULL
L.	NULL
S.	NULL
)	NULL
awarded	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
by	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
Clinical	NULL
Career	NULL
Development	NULL
Award	NULL
(	NULL
to	NULL
R.	NULL
M.	NULL
S.	NULL
)	NULL
,	NULL
and	NULL
by	NULL
a	NULL
Burroughs	NULL
Wellcome	NULL
Clinical	NULL
Pharmacology	NULL
Scholar	NULL
Award	NULL
to	NULL
(	NULL
D.	NULL
W.	NULL
K.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
44	NULL
Binney	NULL
St.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115.	NULL
jun	NULL
fusion	NULL
protein	NULL
.	NULL

The	NULL
carboxyl-terminal	NULL
portion	NULL
of	NULL
was	NULL
shown	NULL
to	NULL
contain	NULL
amino	NULL
acid	NULL
homology	NULL
with	NULL
the	NULL
DNA-binding	NULL
region	NULL
of	NULL
the	NULL
a	NULL
yeast	NULL
GCN4	NULL
regulatory	NULL
protein	NULL
(	NULL
2	NULL
)	NULL
.	NULL

GCN4	NULL
binds	NULL
to	NULL
a	NULL
specific	NULL
DNA	NULL
sequence	NULL
which	NULL
is	NULL
also	NULL
recognized	NULL
by	NULL
the	NULL
mammalian	NULL
transcriptional	NULL
activator	NULL
AP-1	NULL
.	NULL

In-deed	NULL
,	NULL
several	NULL
investigators	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
protooncogene	NULL
c-jun-encoded	NULL
product	NULL
is	NULL
structurally	NULL
and	NULL
functionally	NULL
similar	NULL
,	NULL
if	NULL
not	NULL
identical	NULL
,	NULL
to	NULL
AP-1	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
c-jun	NULL
is	NULL
an	NULL
immediate	NULL
early	NULL
event	NULL
during	NULL
activation	NULL
of	NULL
fibroblasts	NULL
.	NULL

For	NULL
example	NULL
,	NULL
expression	NULL
of	NULL
c-jun	NULL
is	NULL
transcriptionally	NULL
and	NULL
post-transcriptionally	NULL
regulated	NULL
by	NULL
serum	NULL
,	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
,	NULL
and	NULL
fibroblast	NULL
growth	NULL
factor	NULL
in	NULL
mouse	NULL
Balb/c	NULL
3T3	NULL
fibroblasts	NULL
(	NULL
5	NULL
)	NULL
.	NULL

c-jun	NULL
transcription	NULL
is	NULL
rapidly	NULL
induced	NULL
during	NULL
the	NULL
G	NULL
,	NULL
to	NULL
G	NULL
:	NULL
,	NULL
transition	NULL
following	NULL
serum	NULL
stimulation	NULL
of	NULL
quiescent	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Epidermal	NULL
growth	NULL
factor	NULL
also	NULL
stimulates	NULL
transcription	NULL
of	NULL
c-jun	NULL
in	NULL
rat	NULL
fibroblasts	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
nerve	NULL
growth	NULL
factor	NULL
transiently	NULL
induces	NULL
c-jun	NULL
expression	NULL
in	NULL
rat	NULL
PC12	NULL
pheochromocytoma	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
,	NULL
while	NULL
stimulation	NULL
of	NULL
c-jun	NULL
expression	NULL
is	NULL
an	NULL
early	NULL
event	NULL
in	NULL
several	NULL
human	NULL
and	NULL
mouse	NULL
cell	NULL
lines	NULL
after	NULL
exposure	NULL
to	NULL
transforming	NULL
growth	NULL
factor-8	NULL
(	NULL
9	NULL
)	NULL
.	NULL

More	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
tumor	NULL
necrosis	NULL
factor	NULL
induces	NULL
c-jun	NULL
in	NULL
both	NULL
human	NULL
fibroblasts	NULL
and	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
induction	NULL
of	NULL
c-Ha-ras	NULL
onco-protein	NULL
is	NULL
associated	NULL
with	NULL
stimulation	NULL
of	NULL
c-jun	NULL
expression	NULL
in	NULL
mouse	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
using	NULL
a	NULL
heavy	NULL
metal-inducible	NULL
model	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Although	NULL
AP-1	NULL
binds	NULL
to	NULL
DNA	NULL
sequences	NULL
that	NULL
regulate	NULL
transcription	NULL
of	NULL
genes	NULL
responsive	NULL
to	NULL
phorbol	NULL
esters	NULL
(	NULL
13-15	NULL
)	NULL
,	NULL
less	NULL
is	NULL
known	NULL
about	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
agents	NULL
on	NULL
the	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
regulation	NULL
of	NULL
c-jun	NULL
gene	NULL
expression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
treatment	NULL
of	NULL
epithelial	NULL
cells	NULL
with	NULL
12-O-tetra-decanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
``	NULL
is	NULL
associated	NULL
with	NULL
stimulation	NULL
of	NULL
a	NULL
c-jun	NULL
promoter/reporter	NULL
gene	NULL
by	NULL
an	NULL
autoregulatory	NULL
mechanism	NULL
involving	NULL
the	NULL
AP-1	NULL
protein	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
exposure	NULL
of	NULL
human	NULL
fibroblasts	NULL
to	NULL
TPA	NULL
results	NULL
in	NULL
enhanced	NULL
c-jun	NULL
expression	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
,	NULL
treatment	NULL
with	NULL
TPA	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
have	NULL
been	NULL
obtained	NULL
with	NULL
other	NULL
agents	NULL
,	NULL
such	NULL
as	NULL
bryostatin	NULL
1	NULL
,	NULL
which	NULL
also	NULL
activate	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
these	NULL
agents	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
c-jun	NULL
gene	NULL
expression	NULL
during	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
,	NULL
however	NULL
,	NULL
are	NULL
un-known	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
demonstrate	NULL
that	NULL
treatment	NULL
of	NULL
HL-60	NULL
and	NULL
other	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
with	NULL
TPA	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
c-jun	NULL
transcripts	NULL
.	NULL

The	NULL
level	NULL
of	NULL
c-jun	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
both	NULL
transcrip-	NULL
'	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TPA	NULL
,	NULL
12-O-tetradecanoyl-phorbol-13-acetate	NULL
;	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
:	NULL
D	NULL
;	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
;	NULL
SDS	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
;	NULL
TRE	NULL
,	NULL
TPA-responsive	NULL
element	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
(	NULL
s	NULL
)	NULL
.	NULL

3320	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4q	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
Regulation	NULL
of	NULL
c-jun	NULL
during	NULL
Monocytic	NULL
Differentiation	NULL
3321	NULL
tional	NULL
and	NULL
post-transcriptional	NULL
mechanisms	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
bryostatin	NULL
1	NULL
,	NULL
and	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
)	NULL
,	NULL
another	NULL
inducer	NULL
of	NULL
monocytic	NULL
differentiation	NULL
,	NULL
also	NULL
increase	NULL
expression	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-The	NULL
HL-60	NULL
and	NULL
U-937	NULL
cells	NULL
were	NULL
grown	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

THP-1	NULL
monocytic	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
media	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
supplemented	NULL
with	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
.	NULL

Cell	NULL
cultures	NULL
were	NULL
maintained	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
atmosphere	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
32	NULL
nm	NULL
TPA	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
0.5	NULL
um	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
)	NULL
,	NULL
or	NULL
10	NULL
nM	NULL
bryostatin	NULL
1	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
George	NULL
Pettit	NULL
,	NULL
Arizona	NULL
State	NULL
University	NULL
)	NULL
.	NULL

Actinomycin	NULL
D	NULL
and	NULL
cycloheximide	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

Preparation	NULL
of	NULL
RNA	NULL
and	NULL
Northern	NULL
Blot	NULL
Hybridization-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidine	NULL
isothiocyanate-cesium	NULL
chloride	NULL
technique	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
,	NULL
2.2	NULL
M	NULL
formaldehyde	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
one	NULL
of	NULL
the	NULL
following	NULL
P-labeled	NULL
DNA	NULL
probes	NULL
:	NULL
1	NULL
)	NULL
the	NULL
1.8-kb	NULL
BamHI/EcoRI	NULL
insert	NULL
of	NULL
a	NULL
human	NULL
c-jun	NULL
DNA	NULL
probe	NULL
containing	NULL
1.0-kb	NULL
cDNA	NULL
and	NULL
0.8-kb	NULL
3'-untranslated	NULL
sequences	NULL
(	NULL
3	NULL
)	NULL
purified	NULL
from	NULL
a	NULL
pBluescript	NULL
SK	NULL
(	NULL
+	NULL
)	NULL
plasmid	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
R.	NULL
Tijan	NULL
,	NULL
University	NULL
of	NULL
California	NULL
)	NULL
;	NULL
and	NULL
2	NULL
)	NULL
the	NULL
2.0-kb	NULL
Pstl	NULL
insert	NULL
of	NULL
a	NULL
chicken	NULL
B-actin	NULL
cDNA	NULL
gene	NULL
purified	NULL
from	NULL
the	NULL
pAl	NULL
plasmid	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Hybridization	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
for	NULL
16-24	NULL
h	NULL
at	NULL
42	NULL
°C	NULL
in	NULL
50	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
formamide	NULL
,	NULL
2	NULL
x	NULL
SSC	NULL
(	NULL
SSC	NULL
:	NULL
0.15	NULL
M	NULL
sodium	NULL
chloride	NULL
,	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
,	NULL
1	NULL
X	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
200	NULL
ug/ml	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
XAR	NULL
film	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

The	NULL
autoradiograms	NULL
were	NULL
scanned	NULL
using	NULL
an	NULL
LKB	NULL
(	NULL
Bromma	NULL
,	NULL
Sweden	NULL
)	NULL
Ultroscan	NULL
XL	NULL
laser	NULL
densitometer	NULL
and	NULL
analyzed	NULL
using	NULL
the	NULL
Gelscan	NULL
XL	NULL
software	NULL
package	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
c-jun	NULL
hybridization	NULL
was	NULL
normalized	NULL
against	NULL
S-actin	NULL
expression	NULL
.	NULL

Run-on	NULL
Transcriptional	NULL
Analyses-HL-60	NULL
cells	NULL
(	NULL
10°/assay	NULL
)	NULL
were	NULL
washed	NULL
with	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
isolated	NULL
by	NULL
lysis	NULL
in	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
buffer	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
glycerol	NULL
buffer	NULL
and	NULL
incubated	NULL
in	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
reaction	NULL
buffer	NULL
containing	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
each	NULL
of	NULL
ATP	NULL
,	NULL
GTP	NULL
,	NULL
and	NULL
CTP	NULL
,	NULL
and	NULL
200	NULL
LCi	NULL
of	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
UTP	NULL
(	NULL
800	NULL
Ci/mmol	NULL
,	NULL
Du	NULL
Pont-New	NULL
England	NULL
Nuclear	NULL
)	NULL
at	NULL
26	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
100	NULL
l	NULL
of	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
1	NULL
mm	NULL
Na	NULL
,	NULL
EDTA	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mm	NULL
MgCl	NULL
;	NULL
,	NULL
150	NULL
units/ml	NULL
RNasin	NULL
,	NULL
and	NULL
40	NULL
ug/ml	NULL
DNase	NULL
and	NULL
incubated	NULL
at	NULL
28	NULL
°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

After	NULL
proteinase	NULL
K	NULL
digestion	NULL
,	NULL
the	NULL
RNA	NULL
was	NULL
extracted	NULL
with	NULL
phenol/chloroform/isoamyl	NULL
alcohol	NULL
(	NULL
25:24:1	NULL
)	NULL
and	NULL
precipitated	NULL
in	NULL
ethanol	NULL
and	NULL
2.5	NULL
M	NULL
ammonium	NULL
acetate	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
further	NULL
purified	NULL
by	NULL
Sephadex	NULL
G-50	NULL
column	NULL
separation	NULL
.	NULL

Plasmid	NULL
DNAs	NULL
containing	NULL
various	NULL
cloned	NULL
inserts	NULL
were	NULL
digested	NULL
with	NULL
restriction	NULL
endonucleases	NULL
as	NULL
follows	NULL
:	NULL
1	NULL
)	NULL
the	NULL
2.0-kb	NULL
PstI	NULL
fragment	NULL
of	NULL
the	NULL
chicken	NULL
B-actin	NULL
pA1	NULL
plasmid	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
;	NULL
2	NULL
)	NULL
the	NULL
1.1-kb	NULL
BamHI	NULL
insert	NULL
of	NULL
the	NULL
human	NULL
$	NULL
-globin	NULL
gene	NULL
(	NULL
negative	NULL
control	NULL
,	NULL
Ref	NULL
.	NULL

22	NULL
)	NULL
;	NULL
and	NULL
3	NULL
)	NULL
the	NULL
1.8-kb	NULL
BamHI/EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
c-jun	NULL
cDNA	NULL
from	NULL
the	NULL
pBluescript	NULL
SK	NULL
(	NULL
+	NULL
)	NULL
plasmid	NULL
.	NULL

The	NULL
digested	NULL
DNA	NULL
was	NULL
run	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Southern	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
prehybridized	NULL
in	NULL
5	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
40	NULL
%	NULL
formamide	NULL
,	NULL
4	NULL
X	NULL
SSC	NULL
,	NULL
5	NULL
mM	NULL
Na	NULL
;	NULL
EDTA	NULL
,	NULL
0.4	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
yeast	NULL
tRNA	NULL
for	NULL
2	NULL
h.	NULL
Hybridization	NULL
was	NULL
performed	NULL
with	NULL
10	NULL
``	NULL
cpm	NULL
of	NULL
**P	NULL
-labeled	NULL
RNA/m	NULL
!	NULL

of	NULL
hybridization	NULL
buffer	NULL
for	NULL
72	NULL
h	NULL
at	NULL
42	NULL
°C	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
then	NULL
washed	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
10	NULL
ug/ml	NULL
RNase	NULL
A	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
0.1	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
42	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
for	NULL
3-10	NULL
days	NULL
.	NULL

RESULTS	NULL
c-jun	NULL
Transcripts	NULL
Are	NULL
Induced	NULL
by	NULL
TPA	NULL
during	NULL
Human	NULL
Monocytic	NULL
Cell	NULL
Differentiation-The	NULL
effects	NULL
of	NULL
TPA	NULL
on	NULL
c-jun	NULL
expression	NULL
were	NULL
first	NULL
studied	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
HL-60	NULL
cellular	NULL
RNA	NULL
using	NULL
a	NULL
c-jun	NULL
cDNA	NULL
probe	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
a	NULL
2.7-kb	NULL
c-jun	NULL
transcript	NULL
were	NULL
detectable	NULL
in	NULL
untreated	NULL
HL-60	NULL
cells	NULL
,	NULL
increased	NULL
by	NULL
6	NULL
h	NULL
,	NULL
and	NULL
reached	NULL
near	NULL
maximal	NULL
levels	NULL
by	NULL
24	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
32	NULL
nM	NULL
TPA	NULL
.	NULL

TPA	NULL
treatment	NULL
had	NULL
no	NULL
effect	NULL
i	NULL
°	NULL
zI	NULL
)	NULL
HL-60	NULL
6	NULL
h	NULL
12	NULL
h	NULL
24	NULL
h	NULL
285-	NULL
o	NULL
--	NULL
jun	NULL
1ss-	NULL
-	NULL
``	NULL
OQ	NULL
288-	NULL
.	NULL

18s8-	NULL
actin	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Effects	NULL
of	NULL
TPA	NULL
on	NULL
c-jun	NULL
RNA	NULL
levels	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
levels	NULL
was	NULL
performed	NULL
in	NULL
HL-60	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
32	NULL
nM	NULL
TPA	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug/lane	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
*°P	NULL
-labeled	NULL
c-jun	NULL
or	NULL
-actin	NULL
DNA	NULL
probes	NULL
.	NULL

The	NULL
HL-60	NULL
lane	NULL
represents	NULL
RNA	NULL
from	NULL
untreated	NULL
cells	NULL
.	NULL

A.	NULL
TPA	NULL
&	NULL
s	NULL
--	NULL
-I	NULL
1	NULL
c	NULL
o	NULL
¢	NULL
D	NULL
-2885-	NULL
;	NULL
W	NULL
#	NULL
®	NULL
c-jun	NULL
18s-B	NULL
.	NULL

_	NULL
__TPA	NULL
ro-4	NULL
£	NULL
£	NULL
2	NULL
€	NULL
g.	NULL
o	NULL
~	NULL
o	NULL
¢	NULL
-	NULL
a	NULL
~	NULL
if	NULL
28S-	NULL
<	NULL
-	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effects	NULL
of	NULL
TPA	NULL
on	NULL
c-jun	NULL
RNA	NULL
levels	NULL
in	NULL
U-987	NULL
and	NULL
THP-1	NULL
cells	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
levels	NULL
was	NULL
performed	NULL
in	NULL
U-937	NULL
or	NULL
THP-1	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
32	NULL
nm	NULL
TPA	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug/lane	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
**P	NULL
-labeled	NULL
c-jun	NULL
or	NULL
actin	NULL
DNA	NULL
probes	NULL
.	NULL

The	NULL
U-937	NULL
and	NULL
THP-1	NULL
lanes	NULL
represent	NULL
RNA	NULL
from	NULL
untreated	NULL
cells	NULL
.	NULL

Vit	NULL
03	NULL
0	NULL
“	NULL
ID	NULL
&	NULL
a	NULL
-l	NULL
%	NULL
®	NULL
I	NULL
No	NULL
28S-18s-	NULL
w	NULL
c-jun	NULL
28§8-	NULL
_	NULL
,	NULL
188-	NULL
®	NULL
actin	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effects	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
c-jun	NULL
RNA	NULL
levels	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
levels	NULL
was	NULL
performed	NULL
in	NULL
HL-60	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
0.5	NULL
um	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
Vit	NULL
D	NULL
;	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug/lane	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
P-labeled	NULL
c-jun	NULL
or	NULL
$	NULL
-actin	NULL
DNA	NULL
probes	NULL
.	NULL

on	NULL
levels	NULL
of	NULL
actin	NULL
transcripts	NULL
.	NULL

Similar	NULL
kinetics	NULL
of	NULL
c-jun	NULL
induction	NULL
were	NULL
observed	NULL
in	NULL
TPA-treated	NULL
human	NULL
U-937	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
TPA	NULL
was	NULL
also	NULL
associated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
minor	NULL
3.2-kb	NULL
c-jun	NULL
transcript	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

THP-1	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
also	NULL
have	NULL
constitutive	NULL
c-jun	NULL
expression	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
c-jun	NULL
transcripts	NULL
was	NULL
increased	NULL
2.3-fold	NULL
after	NULL
24	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
TPA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Other	NULL
Inducers	NULL
of	NULL
Monocytic	NULL
Differentiation	NULL
Increase	NULL
c-jun	NULL
Expression-In	NULL
contrast	NULL
to	NULL
TPA	NULL
,	NULL
treatment	NULL
of	NULL
HL-60	NULL
cells	NULL
with	NULL
bryostatin	NULL
1	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
less	NULL
rapid	NULL
increase	NULL
in	NULL
c-jun	NULL
transcripts	NULL
.	NULL

For	NULL
example	NULL
,	NULL
low	NULL
levels	NULL
of	NULL
c-jun	NULL
RNA	NULL
were	NULL
present	NULL
after	NULL
24	NULL
h	NULL
,	NULL
and	NULL
maximal	NULL
induction	NULL
was	NULL
observed	NULL
after	NULL
48	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
bryostatin	NULL
1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
effects	NULL
were	NULL
observed	NULL
following	NULL
treatment	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
0.5	NULL
uM	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
.D	NULL
;	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4q	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
38322	NULL
Regulation	NULL
of	NULL
c-jun	NULL
during	NULL
Monocytic	NULL
Differentiation	NULL
multiple	NULL
inducers	NULL
of	NULL
monocytic	NULL
differentiation	NULL
increase	NULL
c-jun	NULL
expression	NULL
in	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
.	NULL

c-jun	NULL
Expression	NULL
Is	NULL
Regulated	NULL
at	NULL
Both	NULL
the	NULL
Transcriptional	NULL
and	NULL
Post-transcriptional	NULL
Levels	NULL
by	NULL
TPA-In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
increased	NULL
levels	NULL
of	NULL
c-jun	NULL
RNA	NULL
are	NULL
associated	NULL
with	NULL
transcriptional	NULL
activation	NULL
and/or	NULL
enhanced	NULL
stabilization	NULL
of	NULL
the	NULL
c-jun	NULL
transcript	NULL
,	NULL
HL-60	NULL
cells	NULL
were	NULL
first	NULL
treated	NULL
with	NULL
TPA	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
cycloheximide	NULL
.	NULL

Little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
c-jun	NULL
RNA	NULL
was	NULL
detectable	NULL
after	NULL
2	NULL
or	NULL
4	NULL
h	NULL
of	NULL
TPA	NULL
treatment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
with	NULL
cycloheximide	NULL
alone	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
c-jun	NULL
RNA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
cycloheximide	NULL
and	NULL
TPA	NULL
for	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
24	NULL
h	NULL
increased	NULL
levels	NULL
of	NULL
c-jun	NULL
transcripts	NULL
as	NULL
compared	NULL
with	NULL
treatment	NULL
with	NULL
either	NULL
TPA	NULL
or	NULL
cycloheximide	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
cycloheximide	NULL
superinduces	NULL
c-jun	NULL
expression	NULL
,	NULL
and	NULL
thus	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
c-jun	NULL
RNA	NULL
by	NULL
TPA	NULL
.	NULL

Run-on	NULL
assays	NULL
were	NULL
also	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
transcriptional	NULL
mechanisms	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
c-jun	NULL
gene	NULL
expression	NULL
.	NULL

c-jun	NULL
gene	NULL
transcription	NULL
was	NULL
detectable	NULL
in	NULL
untreated	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
exposure	NULL
to	NULL
TPA	NULL
for	NULL
24	NULL
h	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
3.3-fold	NULL
increase	NULL
in	NULL
c-jun	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cycloheximide	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
rates	NULL
of	NULL
c-jun	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
cycloheximide	NULL
affects	NULL
c-jun	NULL
expression	NULL
by	NULL
a	NULL
post-transcriptional	NULL
mechanism	NULL
,	NULL
perhaps	NULL
by	NULL
stabilizing	NULL
the	NULL
c-jun	NULL
transcript	NULL
.	NULL

In	NULL
order	NULL
to	NULL
study	NULL
the	NULL
post-transcriptional	NULL
regulation	NULL
of	NULL
TPA-induced	NULL
c-jun	NULL
RNA	NULL
levels	NULL
,	NULL
HL-60	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
for	NULL
18	NULL
h	NULL
to	NULL
induce	NULL
c-jun	NULL
expression	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
actinomycin	NULL
D	NULL
for	NULL
various	NULL
times	NULL
to	NULL
inhibit	NULL
further	NULL
transcription	NULL
.	NULL

The	NULL
half-life	NULL
of	NULL
c-jun	NULL
RNA	NULL
as	NULL
determined	NULL
by	NULL
densito-metric	NULL
scanning	NULL
was	NULL
30	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
with	NULL
cycloheximide	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
transcription	NULL
increased	NULL
the	NULL
half-life	NULL
of	NULL
c-jun	NULL
RNA	NULL
in	NULL
TPA	NULL
TPA	NULL
CHX	NULL
_	NULL
CHX/TPA	NULL
288-	NULL
»	NULL
w	NULL
tn	NULL
®	NULL
0	NULL
_..	NULL
1ss-	NULL
.	NULL

``	NULL
m	NULL
actin	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Effects	NULL
of	NULL
cycloheximide	NULL
on	NULL
c-jun	NULL
RNA	NULL
levels	NULL
in	NULL
untreated	NULL
and	NULL
TPA-treated	NULL
HL-60	NULL
cells	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
and/or	NULL
5	NULL
ug/ml	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
for	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
24	NULL
h.	NULL
Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug/lane	NULL
)	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
hybridization	NULL
to	NULL
a	NULL
**P	NULL
-labeled	NULL
c-jun	NULL
probe	NULL
.	NULL

M	NULL
a	NULL
€	NULL
§	NULL
5	NULL
kb	NULL
#	NULL
&	NULL
4	NULL
Control	NULL
TPA	NULL
CHX	NULL
CHX/TPA	NULL
4.9	NULL
fu	NULL
ge	NULL
``	NULL
i	NULL
2.0	NULL
;	NULL
--	NULL
I	NULL
E	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
TPA	NULL
on	NULL
rates	NULL
of	NULL
c-jun	NULL
gene	NULL
transcription	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
for	NULL
24	NULL
h	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
ug/ml	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
newly	NULL
elongated	NULL
``	NULL
P-labeled	NULL
RNA	NULL
transcripts	NULL
were	NULL
hybridized	NULL
to	NULL
2	NULL
ug	NULL
of	NULL
c-jun	NULL
,	NULL
B-globin	NULL
,	NULL
or	NULL
G-actin	NULL
DNA	NULL
insert	NULL
after	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
and	NULL
Southern	NULL
blotting	NULL
.	NULL

As	NULL
compared	NULL
with	NULL
that	NULL
for	NULL
the	NULL
actin	NULL
gene	NULL
,	NULL
c-jun	NULL
gene	NULL
transcription	NULL
was	NULL
increased	NULL
3.3-fold	NULL
following	NULL
treatment	NULL
with	NULL
TPA	NULL
.	NULL

Similar	NULL
findings	NULL
(	NULL
1.9-	NULL
and	NULL
4.8-fold	NULL
increases	NULL
)	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

In	NULL
the	NULL
schematic	NULL
diagram	NULL
on	NULL
the	NULL
left	NULL
,	NULL
the	NULL
solid	NULL
lines	NULL
represent	NULL
the	NULL
relative	NULL
position	NULL
of	NULL
the	NULL
cDNA	NULL
inserts	NULL
,	NULL
while	NULL
the	NULL
dashed	NULL
lines	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
the	NULL
plasmid	NULL
vectors	NULL
.	NULL

288-	NULL
,	NULL
:	NULL
>	NULL
8000008	NULL
«	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effects	NULL
of	NULL
cycloheximide	NULL
on	NULL
c-jun	NULL
RNA	NULL
half-life	NULL
in	NULL
TPA-treated	NULL
HL-60	NULL
cells	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
32	NULL
nM	NULL
TPA	NULL
for	NULL
18	NULL
h	NULL
followed	NULL
by	NULL
5	NULL
ug/ml	NULL
actinomycin	NULL
D	NULL
(	NULL
Act	NULL
)	NULL
or	NULL
actinomycin	NULL
D	NULL
and	NULL
5	NULL
ug/ml	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
)	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
.	NULL

treated	NULL
HL-60	NULL
cells	NULL
to	NULL
greater	NULL
than	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggested	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
c-jun	NULL
RNA	NULL
observed	NULL
during	NULL
TPA	NULL
treatment	NULL
is	NULL
also	NULL
mediated	NULL
by	NULL
post-transcriptional	NULL
mechanisms	NULL
involving	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
labile	NULL
protein	NULL
which	NULL
affects	NULL
the	NULL
turnover	NULL
of	NULL
c-jun	NULL
RNA	NULL
.	NULL

DISCUSSION	NULL
The	NULL
present	NULL
results	NULL
indicate	NULL
that	NULL
TPA	NULL
induces	NULL
c-jun	NULL
expression	NULL
in	NULL
several	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
.	NULL

Bryostatin	NULL
1	NULL
treatment	NULL
was	NULL
also	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
c-jun	NULL
RNA	NULL
levels	NULL
,	NULL
although	NULL
the	NULL
kinetics	NULL
were	NULL
somewhat	NULL
less	NULL
rapid	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
TPA	NULL
.	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
,	NULL
as	NULL
in	NULL
epithelial	NULL
cells	NULL
and	NULL
fibroblasts	NULL
(	NULL
10	NULL
,	NULL
16	NULL
)	NULL
,	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
present	NULL
results	NULL
also	NULL
demonstrate	NULL
that	NULL
c-jun	NULL
expression	NULL
is	NULL
increased	NULL
in	NULL
these	NULL
cells	NULL
following	NULL
treatment	NULL
with	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

This	NULL
agent	NULL
binds	NULL
to	NULL
a	NULL
cytosolic	NULL
protein	NULL
and	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
to	NULL
activate	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
other	NULL
signaling	NULL
mechanisms	NULL
may	NULL
regulate	NULL
c-jun	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
cAMP	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
in	NULL
rat	NULL
pheochromocytoma	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
present	NULL
findings	NULL
also	NULL
suggest	NULL
that	NULL
post-transcriptional	NULL
mechanisms	NULL
requiring	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
regulate	NULL
c-jun	NULL
gene	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
by	NULL
cycloheximide	NULL
superinduced	NULL
levels	NULL
of	NULL
c-jun	NULL
transcripts	NULL
during	NULL
TPA	NULL
treatment	NULL
.	NULL

Furthermore	NULL
,	NULL
while	NULL
cycloheximide	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
c-Jun	NULL
gene	NULL
transcription	NULL
,	NULL
this	NULL
agent	NULL
did	NULL
prolong	NULL
the	NULL
half-life	NULL
of	NULL
the	NULL
c-jun	NULL
transcript	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
,	NULL
as	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
RNA	NULL
levels	NULL
for	NULL
certain	NULL
cytokines	NULL
and	NULL
other	NULL
protooncogenes	NULL
,	NULL
c-jun	NULL
transcripts	NULL
may	NULL
be	NULL
selectively	NULL
processed	NULL
and	NULL
degraded	NULL
by	NULL
labile	NULL
ribonu-cleases	NULL
in	NULL
myeloid	NULL
cells	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Similar	NULL
mechanisms	NULL
of	NULL
post-transcriptional	NULL
regulation	NULL
by	NULL
serum	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
c-jun	NULL
gene	NULL
in	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
and	NULL
are	NULL
probably	NULL
related	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
AU-rich	NULL
region	NULL
in	NULL
the	NULL
untranslated	NULL
3	NULL
'	NULL
region	NULL
of	NULL
this	NULL
transcript	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
c-jun	NULL
protooncogene	NULL
contains	NULL
a	NULL
highly	NULL
conserved	NULL
DNA	NULL
binding	NULL
domain	NULL
with	NULL
high	NULL
affinity	NULL
for	NULL
the	NULL
TPA-responsive	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
.	NULL

This	NULL
domain	NULL
,	NULL
also	NULL
shared	NULL
by	NULL
a	NULL
family	NULL
of	NULL
mammalian	NULL
transcription	NULL
factors	NULL
including	NULL
junB	NULL
,	NULL
junD	NULL
,	NULL
c-fos	NULL
,	NULL
fosB	NULL
,	NULL
fra-1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
yeast	NULL
GCN4	NULL
protein	NULL
,	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
regions	NULL
,	NULL
a	NULL
leucine	NULL
zipper	NULL
and	NULL
a	NULL
region	NULL
rich	NULL
in	NULL
basic	NULL
amino	NULL
acids	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
leucine	NULL
zipper	NULL
allows	NULL
for	NULL
dimeri-zation	NULL
between	NULL
certain	NULL
members	NULL
of	NULL
this	NULL
family	NULL
while	NULL
the	NULL
basic	NULL
motif	NULL
is	NULL
necessary	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
TRE	NULL
(	NULL
27-30	NULL
)	NULL
.	NULL

Specific	NULL
protein	NULL
complexes	NULL
contribute	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
affinity	NULL
(	NULL
30-34	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
c-jun/c-fos	NULL
heterodimers	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
TRE	NULL
25	NULL
times	NULL
more	NULL
efficiently	NULL
than	NULL
c-jun	NULL
homo-	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4q	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
Regulation	NULL
of	NULL
c-jun	NULL
during	NULL
Monocytic	NULL
Differentiation	NULL
dimers	NULL
,	NULL
while	NULL
c-fos	NULL
homodimers	NULL
have	NULL
little	NULL
affinity	NULL
for	NULL
the	NULL
TRE	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
c-fos	NULL
expression	NULL
is	NULL
a	NULL
rapid	NULL
event	NULL
during	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
by	NULL
TPA	NULL
,	NULL
bryostatin	NULL
1	NULL
,	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
18	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
c-fos	NULL
transcripts	NULL
in	NULL
TPA-treated	NULL
HL-60	NULL
cells	NULL
precedes	NULL
that	NULL
for	NULL
the	NULL
c-jun	NULL
gene	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
c-fos/c-jun	NULL
heterodimers	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
c-jun	NULL
expression	NULL
by	NULL
TPA	NULL
and	NULL
other	NULL
inducers	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

HL-60	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
express	NULL
histochemical	NULL
,	NULL
mor-phological	NULL
,	NULL
and	NULL
functional	NULL
characteristics	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
induction	NULL
of	NULL
c-fos	NULL
transcripts	NULL
,	NULL
monocytic	NULL
differentiation	NULL
is	NULL
associated	NULL
with	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
certain	NULL
other	NULL
protooncogenes	NULL
and	NULL
growth	NULL
regulatory	NULL
genes	NULL
.	NULL

For	NULL
example	NULL
,	NULL
TPA-induced	NULL
HL-60	NULL
cell	NULL
differentiation	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
decrease	NULL
in	NULL
c-myc	NULL
transcripts	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Of	NULL
potential	NULL
relevance	NULL
is	NULL
the	NULL
finding	NULL
that	NULL
formation	NULL
of	NULL
c-jun/c-fos	NULL
heterodimers	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
down-regulation	NULL
of	NULL
the	NULL
c-myc	NULL
gene	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Monocytic	NULL
differentiation	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
c-fms	NULL
,	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
,	NULL
macrophage-specific	NULL
colony	NULL
stimulating	NULL
factor	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
transcripts	NULL
(	NULL
35	NULL
,	NULL
37-40	NULL
)	NULL
.	NULL

While	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
induction	NULL
of	NULL
AP-1	NULL
is	NULL
required	NULL
for	NULL
the	NULL
changes	NULL
observed	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
macrophage-specific	NULL
colony	NULL
stimulating	NULL
factor	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
are	NULL
known	NULL
to	NULL
contain	NULL
AP-1-like	NULL
sites	NULL
in	NULL
their	NULL
5	NULL
upstream	NULL
promoter	NULL
regions	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
AP-1	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
certain	NULL
genes	NULL
required	NULL
for	NULL
the	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
monocytes	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
by	NULL
TPA	NULL
and	NULL
other	NULL
inducers	NULL
of	NULL
monocytic	NULL
differentiation	NULL
regulates	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
by	NULL
functioning	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Maki	NULL
,	NULL
Y.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
C.	NULL
,	NULL
Starbuck	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
2848-2852	NULL
2	NULL
.	NULL

Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Doolittle	NULL
,	NULL
R.	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
8316-3319	NULL
3	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Allegretto	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Okino	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
382	NULL
,	NULL
166-171	NULL
4	NULL
.	NULL

Bohmann	NULL
,	NULL
D.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
Nishimura	NULL
,	NULL
T.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Tijan	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
238	NULL
,	NULL
1386-1392	NULL
5	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8464-8467	NULL
6	NULL
.	NULL

Ryseck	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Hirai	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Yaniv	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
334	NULL
,	NULL
535-537	NULL
7	NULL
.	NULL

Quantin	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Breathnach	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
884	NULL
,	NULL
538-539	NULL
8	NULL
.	NULL

Wu	NULL
,	NULL
B.	NULL
,	NULL
Fodor	NULL
,	NULL
E.	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Edwards	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
9000-9003	NULL
9	NULL
.	NULL

Pertovaara	NULL
,	NULL
L.	NULL
,	NULL
Sistonen	NULL
,	NULL
L.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Keski-Oja	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Alitalo	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
1255-1262	NULL
10	NULL
.	NULL

Brenner	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
O'Hara	NULL
,	NULL
M.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Chojkier	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
337	NULL
,	NULL
661-663	NULL
3328	NULL
11	NULL
.	NULL

Dixit	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
Marks	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Sarma	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Prochownik	NULL
,	NULL
E.	NULL
V.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
16905-16909	NULL
12	NULL
.	NULL

Sistonen	NULL
,	NULL
L.	NULL
,	NULL
Holtta	NULL
,	NULL
E.	NULL
,	NULL
Maekla	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Keski-Oja	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Alitalo	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
815-822	NULL
13	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rahms-dorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
729-739	NULL
14	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
Mitchell	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Tijan	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
741-752	NULL
15	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Bockoven	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
329	NULL
,	NULL
648-651	NULL
16	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
875-885	NULL
17	NULL
.	NULL

Rovera	NULL
,	NULL
G.	NULL
,	NULL
O'Brien	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
and	NULL
Diamond	NULL
,	NULL
L.	NULL
(	NULL
1979	NULL
)	NULL
Science	NULL
204	NULL
,	NULL
868-870	NULL
18	NULL
.	NULL

Stone	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Sariban	NULL
,	NULL
E.	NULL
,	NULL
Pettit	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Blood	NULL
72	NULL
,	NULL
208-213	NULL
19	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Weber	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85	NULL
,	NULL
in	NULL
press	NULL
20	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
Mitchell	NULL
,	NULL
T.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

138	NULL
,	NULL
1954-1958	NULL
21	NULL
.	NULL

Cleveland	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Lopata	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Cowan	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Rutter	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
Kirschner	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1980	NULL
)	NULL
Cell	NULL
20	NULL
,	NULL
95-105	NULL
22	NULL
.	NULL

Wilson	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Wilson	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
deRiel	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Villa-Komaroff	NULL
,	NULL
L.	NULL
,	NULL
Efstratiadis	NULL
,	NULL
A.	NULL
,	NULL
Forget	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1978	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

5	NULL
,	NULL
563-580	NULL
23	NULL
.	NULL

Ostrem	NULL
,	NULL
V.	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
Lee	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Perlman	NULL
,	NULL
K.	NULL
,	NULL
Prahl	NULL
,	NULL
J.	NULL
,	NULL
Schnoes	NULL
,	NULL
H.	NULL
K.	NULL
,	NULL
DeLuca	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
and	NULL
Ikekawa	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
14164-14171	NULL
24	NULL
.	NULL

Caput	NULL
,	NULL
D.	NULL
,	NULL
Beutler	NULL
,	NULL
B.	NULL
,	NULL
Hertog	NULL
,	NULL
K.	NULL
,	NULL
Thayer	NULL
,	NULL
R.	NULL
,	NULL
Brown-Shimmer	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

83	NULL
,	NULL
1670-1674	NULL
25	NULL
.	NULL

Shaw	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Kamen	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
659-667	NULL
26	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Tijan	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
245	NULL
,	NULL
371-378	NULL
27	NULL
.	NULL

Kouzarides	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ziff	NULL
,	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
836	NULL
,	NULL
646-651	NULL
28	NULL
.	NULL

Kouzarides	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ziff	NULL
,	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
840	NULL
,	NULL
568-571	NULL
29	NULL
.	NULL

Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
Ransone	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
336	NULL
,	NULL
692-695	NULL
30	NULL
.	NULL

Gentz	NULL
,	NULL
R.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Abate	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
1695-1699	NULL
31	NULL
.	NULL

Halazonetis	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Geenberg	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
917-924	NULL
32	NULL
.	NULL

Turner	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Tijan	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
243	NULL
,	NULL
1689-1694	NULL
33	NULL
.	NULL

Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
907-915	NULL
34	NULL
.	NULL

Zerial	NULL
,	NULL
M.	NULL
,	NULL
Toschi	NULL
,	NULL
L.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Schuermann	NULL
,	NULL
M.	NULL
,	NULL
Muller	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
805-813	NULL
35	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
Mitchell	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
816	NULL
,	NULL
64-66	NULL
36	NULL
.	NULL

Takimoto	NULL
,	NULL
M.	NULL
,	NULL
Quinn	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Farina	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Levens	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
8992-8999	NULL
37	NULL
.	NULL

Horiguchi	NULL
,	NULL
J.	NULL
,	NULL
Warren	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

141	NULL
,	NULL
924-930	NULL
38	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

48	NULL
,	NULL
4498-4502	NULL
39	NULL
.	NULL

Pantazis	NULL
,	NULL
P.	NULL
,	NULL
Sariban	NULL
,	NULL
E.	NULL
,	NULL
Kufe	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Antoniades	NULL
,	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
6455-6459	NULL
40	NULL
.	NULL

Horiguchi	NULL
,	NULL
J.	NULL
,	NULL
Spriggs	NULL
,	NULL
D.	NULL
,	NULL
Imamura	NULL
,	NULL
J.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
,	NULL
Luebbers	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
252-258	NULL
41	NULL
.	NULL

Ladner	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Martin	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Noble	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Nikoloff	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Tal	NULL
,	NULL
R.	NULL
,	NULL
Kawasaki	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
and	NULL
White	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
2693-2698	NULL
42	NULL
.	NULL

Economou	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Rhoades	NULL
,	NULL
K.	NULL
,	NULL
Essner	NULL
,	NULL
R.	NULL
,	NULL
McBride	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Morton	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170	NULL
,	NULL
321-326	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4q	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
Transcriptional	NULL
and	NULL
post-transcriptional	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

ML	NULL
Sherman	NULL
,	NULL
R	NULL
M	NULL
Stone	NULL
,	NULL
R	NULL
Datta	NULL
,	NULL
S	NULL
H	NULL
Bernstein	NULL
and	NULL
D	NULL
W	NULL
Kufe	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1990	NULL
,	NULL
265:3320-3323	NULL
.	NULL

Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/265/6/3320	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
0	NULL
references	NULL
,	NULL
0	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
full.html	NULL
#	NULL
ref-list-	NULL
1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wos	NULL
;	NULL

